Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations

Hospital Saint Joseph

Status: Completed

Conditions: Pancreatitis, Chronic

Treatments: Device: SpyGlass DS

Study type: Interventional

Funder types: Other

Identifiers

NCT04672642

SPY PCC 2020

Details and patient eligibility

About

The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.

Enrollment: 27 patients

Sex: All

Ages: 18+ months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• aged 18 and over;
• with chronic calcifying pancreatitis;
• having already received endoscopic treatment for pancreatic pain related to stenosis and / or pancreatic stones;
• having given free, informed and written consent;
• being affiliated to a social security scheme or beneficiary of such a scheme.

Exclusion criteria

• contraindications to performing an upper digestive endoscopy;
• haemorrhagic disease, haemostasis and coagulation disorder (PR <60%, PTT> 40 s and platelets <60,000 / mm3;
• pregnant or breastfeeding woman;
• adult patient protected (guardianship or curatorship), or deprived of liberty by a judicial or administrative decision;
• person subject to a safeguard measure.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

27 participants in 1 patient group

SpyGlass DS after endoscopic treatment

Experimental group

Treatment:

Device: SpyGlass DS